Full text is available at the source.
Abstract
Pooled estimates of alopecia risk associated with GLP-1 receptor agonists are currently unavailable.
- Alopecia has been identified as a significant adverse effect of GLP-1 receptor agonists.
- Quantitative estimates of alopecia risk are lacking and need to be stratified by subtype and specific agent.
- The study aims to provide a comprehensive analysis of alopecia risk and its potential mechanisms.
- Follow-up duration will also be considered in the assessment of alopecia risk related to GLP-1 receptor agonists.
Simplified